Home › Stocks › ZVRA

Zevra Therapeutics, Inc. (ZVRA): insider buying, hedge funds & Congress trades

Zevra Therapeutics, Inc. (ZVRA): 5 insider purchases in the last two years.

Insider buying

FiledInsiderSharesPriceValueType
Sep 16, 2025Favorito Tamara A
Director
3,175$7.79$24.7Kno history
Sep 15, 2025Shih Alvin
Director
20,000$7.89$157.8Kno history
Aug 20, 2025Bode John B
Director
5,000$9.17$45.9Kno history
Mar 31, 2025Watton Corey Michael
Director
300$7.84$2.4Kno history
Mar 21, 2025Bode John B
Director
10,000$7.96$79.6Kno history

Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.

Get alerts for ZVRA

Free account. Know when insiders, famous funds or Congress trade it.

Start free